Pomdoctor vs Yunji
POM and YJ side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How POM and YJ compare
Pomdoctor grew revenue faster over the last twelve months (16.7% versus −24.1% for Yunji).
Yunji scores higher on the StockData Score (2 against 1 for Pomdoctor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | POM | YJ |
|---|---|---|
| Size and price | ||
| Share price | $1.62 | $1.33 |
| Change, 1 year | −98.3% | −21.8% |
| Change, 5 years | – | −95.8% |
| Beta (5Y) | 1.22 | 0.71 |
| Employees | 10K | 31 |
| StockData Score | ||
| Total score | 1 | 2 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 16.7% (better) | −24.1% |
| Revenue growth, 5Y average | – | −43.5% |
| Profitability | ||
| Gross margin | 13.1% | 44.4% (better) |
| Operating margin | −29.7% (better) | −45.2% |
| Net margin | – | −42.0% |
| FCF margin | −37.4% (better) | −39.9% |
| Return on equity | – | −13.2% |
| Return on invested capital | – | −13.8% |
| Financial health | ||
| Debt / equity | – | 0.04 |
| Interest coverage | −30.1× (better) | −271.1× |
| Current ratio | 0.35 | 1.41 (better) |
| Piotroski F-score | – | 2 |
| Ownership | ||
| Held by institutions | 0.11% | 5.5% |
| Held by insiders | 28.1% | 24.5% |
Go deeper
- POM stock overview
- POM income statement
- POM valuation and score
- YJ stock overview
- YJ income statement
- YJ valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.